Zeria Pharmaceutical Co., Ltd. (4559.T)
JPY 2454.0
(1.95%)
JPY 2454.0
(1.95%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 75.72 Billion | 68.38 Billion | 59.53 Billion | 55.43 Billion | 60.43 Billion | 61.82 Billion |
| Cost of Revenue | 25.54 Billion | 18.89 Billion | 17.38 Billion | 15.79 Billion | 16.64 Billion | 17.75 Billion |
| Gross Profit | 50.18 Billion | 49.48 Billion | 42.14 Billion | 39.63 Billion | 43.79 Billion | 44.07 Billion |
| Operating Expenses | 40.46 Billion | 40.47 Billion | 35.78 Billion | 36.19 Billion | 39.69 Billion | 40.33 Billion |
| Selling, General and Administrative Expenses | 36.73 Billion | 32.64 Billion | 30.99 Billion | 30.78 Billion | 33.43 Billion | 33.5 Billion |
| Research and Development Expenses | 3.72 Billion | 3.45 Billion | 4.78 Billion | 5.41 Billion | 6.34 Billion | 6.83 Billion |
| Other Expenses | - | 21.78 Million | 5.58 Million | 38.65 Million | 36.94 Million | 29.21 Million |
| Cost and Expenses | 66 Billion | 59.36 Billion | 53.16 Billion | 51.98 Billion | 56.34 Billion | 58.08 Billion |
| Operating Income | 9.71 Billion | 9.01 Billion | 6.36 Billion | 3.44 Billion | 4.09 Billion | 3.73 Billion |
| Interest Expense | 457.8 Million | 337.28 Million | 315.46 Million | 238.19 Million | 228.63 Million | 199.64 Million |
| Income Tax Expense | 1.81 Billion | 1.06 Billion | 1.74 Billion | 791.4 Million | 981.46 Million | 1.75 Billion |
| Earnings before Tax | 9.5 Billion | 7.27 Billion | 5.72 Billion | 3.92 Billion | 3.92 Billion | 5.22 Billion |
| Net Income | 7.73 Billion | 6.19 Billion | 3.96 Billion | 3.14 Billion | 2.92 Billion | 3.45 Billion |
| Earnings Per Share Basic | 175.39 | 140.26 | 87.76 | 68.22 | 62.62 | 69.56 |
| Earnings Per Share Diluted | 175.39 | 140.26 | 87.76 | 68.22 | 62.62 | 69.56 |
| Weighted Average Shares Outstanding | 44.08 Million | 44.17 Million | 45.13 Million | 46.07 Million | 46.71 Million | 49.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.08 Million | 44.17 Million | 45.13 Million | 46.07 Million | 46.71 Million | 49.65 Million |
| Gross Margin | 0.66 | 0.72 | 0.71 | 0.72 | 0.72 | 0.71 |
| EBIT Margin | 0.23 | 0.21 | 0.20 | 0.14 | 0.13 | 0.12 |
| Profit Margin | 0.10 | 0.09 | 0.07 | 0.06 | 0.05 | 0.06 |
| EBITDA | 17.52 Billion | 13.75 Billion | 11.43 Billion | 8.63 Billion | 8.09 Billion | 9.15 Billion |
| Earnings Before Tax Margin | 0.13 | 0.13 | 0.11 | 0.06 | 0.07 | 0.06 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 21.45 Billion | 17.8 Billion | 75.72 Billion | 21.24 Billion | 18.37 Billion | 18.3 Billion |
| Cost of Revenue | 5.47 Billion | 5.17 Billion | 25.54 Billion | 5.41 Billion | 5.05 Billion | 4.57 Billion |
| Gross Profit | 15.97 Billion | 12.63 Billion | 50.18 Billion | 15.82 Billion | 13.31 Billion | 13.73 Billion |
| Operating Expenses | 10.68 Billion | 12.49 Billion | 40.46 Billion | 11.66 Billion | 10.95 Billion | 10.76 Billion |
| Selling, General and Administrative Expenses | 12.03 Billion | 11.44 Billion | - | 10.72 Billion | 10.1 Billion | 10.76 Billion |
| Research and Development Expenses | - | 1.04 Billion | - | 931 Million | 855 Million | 891 Million |
| Other Expenses | - | 99.96 Million | 169.36 Million | -85.34 Million | 20.6 Million | 134.13 Million |
| Cost and Expenses | 16.15 Billion | 17.67 Billion | 66 Billion | 17.07 Billion | 16.01 Billion | 15.33 Billion |
| Operating Income | 3.93 Billion | 132.97 Million | 9.71 Billion | 4.16 Billion | 2.35 Billion | 2.97 Billion |
| Interest Expense | 115.16 Million | 111.48 Million | 457.8 Million | 120.2 Million | 115.38 Million | 110.72 Million |
| Income Tax Expense | 1.22 Billion | 55.56 Million | 1.81 Billion | 752.55 Million | 563.13 Million | 441.92 Million |
| Earnings before Tax | 5.46 Billion | -687.1 Million | 9.5 Billion | 3.78 Billion | 3.05 Billion | 3.35 Billion |
| Net Income | 4.21 Billion | -692.07 Million | 7.73 Billion | 3.02 Billion | 2.48 Billion | 2.91 Billion |
| Earnings Per Share Basic | 95.55 | -15.70 | - | 68.66 | 56.29 | 66.14 |
| Earnings Per Share Diluted | 95.55 | -15.70 | - | 68.66 | 56.29 | 66.14 |
| Weighted Average Shares Outstanding | 44.07 Million | 44.07 Million | 44.08 Million | 44.07 Million | 44.08 Million | 44.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.07 Million | 44.07 Million | 44.08 Million | 44.07 Million | 44.08 Million | 44.08 Million |
| Gross Margin | 0.74 | 0.71 | 0.66 | 0.74 | 0.72 | 0.75 |
| EBIT Margin | 0.27 | 0.14 | - | 0.19 | 0.12 | 0.19 |
| Profit Margin | 0.20 | -0.04 | 0.10 | 0.14 | 0.14 | 0.16 |
| EBITDA | 5.82 Billion | 2.46 Billion | - | 4.06 Billion | 2.25 Billion | 3.46 Billion |
| Earnings Before Tax Margin | 0.18 | 0.01 | 0.13 | 0.20 | 0.13 | 0.16 |
6892
1629
HAIVF
GTHKF
PGUN
LECBF